Fiche publication
Date publication
juin 2026
Journal
JAMA oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie
Tous les auteurs :
Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Achard V, Vial N, McDonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R
Lien Pubmed
Résumé
Stereotactic body radiotherapy (SBRT), most commonly delivered in 5 fractions, is an established treatment option for patients with localized prostate cancer. While efforts to further reduce treatment to fewer than 5 fractions are ongoing, the efficacy and tolerability of single high-dose SBRT remain to be established.
Référence
JAMA Oncol. 2026 06 18;:
